Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infectio... by Elias, S, Collins, K, Halstead, F, Choudhary, P, Bliss, C, Ewer, K, Sheehy, S, Duncan, C, Biswas, S, Hill, A, Draper, S

Viral vectored blood-stage malaria vaccines induce B cell responses in humans that can be boosted by controlled malaria infection by Elias, S, Choudhary, P, de Cassan, S, Biswas, S, Collins, K, Halstead, F, Bliss, C, Ewer, K, Sheehy, S, Duncan, C, Hill, A, Draper, S

Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. by Elias, S, Choudhary, P, de Cassan, S, Biswas, S, Collins, K, Halstead, F, Bliss, C, Ewer, K, Hodgson, S, Duncan, C, Hill, A, Draper, S

Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure by Biswas, S, Choudhary, P, Elias, S, Miura, K, Milne, K, De Cassan, S, Collins, K, Halstead, F, Bliss, C, Ewer, K, Osier, F, Hodgson, S, Duncan, C, O'Hara, G, Long, C, Hill, A, Draper, S

CLINICAL EVALUATION OF NEW VIRAL VECTORED VACCINES TARGETING THE PLASMODIUM FALCIPARUM BLOOD-STAGE ANTIGENS; MSP1 AND AMA1 by Sheehy, S, Duncan, C, Anagnostou, N, Elias, S, Halstead, F, Collins, K, Ewer, K, Edwards, N, Douglas, A, Gantlett, K, Lawrie, A, Berrie, E, Moyles, S, Long, C, Sinden, R, Blagborough, A, Murphy, J, Nicosia, A, Hill, A, Draper, S

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALA... by Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Halstead, F, Edwards, N, Collins, K, Lillie, P, Poulton, I, Hunt-Cooke, A, Lawrie, A, Draper, S, Gilbert, S, Fay, M, Miura, K, Long, C, Wu, Y, Hill, A, Ellis, R

Phase Ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors by Sheehy, S, Duncan, C, Elias, S, Collins, K, Ewer, K, Spencer, A, Williams, A, Halstead, F, Moretz, SE, Miura, K, Epp, C, Dicks, M, Poulton, I, Lawrie, A, Berrie, E, Moyle, S, Long, C, Colloca, S, Cortese, R, Gilbert, S, Nicosia, A, Hill, A, Draper, S

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans by Sheehy, S, Duncan, C, Elias, S, Choudhary, P, Biswas, S, Halstead, F, Collins, K, Edwards, N, Douglas, A, Anagnostou, N, Ewer, K, Havelock, T, Havelock, T, Mahungu, T, Bliss, C, Miura, K, Poulton, I, Lillie, P, Antrobus, R, Berrie, E, Moyle, S, Gantlett, K, Colloca, S, Colloca, S, Cortese, R

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. by Sheehy, S, Duncan, C, Elias, S, Collins, K, Ewer, K, Spencer, A, Williams, A, Halstead, F, Moretz, SE, Miura, K, Epp, C, Dicks, MD, Poulton, I, Lawrie, A, Berrie, E, Moyle, S, Long, C, Colloca, S, Cortese, R, Gilbert, S, Nicosia, A, Hill, A, Draper, S

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. by Sheehy, S, Duncan, C, Elias, S, Choudhary, P, Biswas, S, Halstead, F, Collins, K, Edwards, N, Douglas, A, Anagnostou, N, Ewer, K, Havelock, T, Mahungu, T, Bliss, C, Miura, K, Poulton, I, Lillie, P, Antrobus, R, Berrie, E, Moyle, S, Gantlett, K, Colloca, S, Cortese, R, Long, C, Sinden, R

Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. by Sheehy, S, Duncan, C, Elias, S, Biswas, S, Collins, K, O'Hara, G, Halstead, F, Ewer, K, Mahungu, T, Spencer, A, Miura, K, Poulton, I, Dicks, M, Edwards, N, Berrie, E, Moyle, S, Colloca, S, Cortese, R, Gantlett, K, Long, C, Lawrie, A, Gilbert, S, Doherty, T, Nicosia, A, Hill, A, Draper, S

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector. by O'Hara, G, Duncan, C, Ewer, K, Collins, K, Elias, S, Halstead, F, Goodman, A, Edwards, N, Reyes-Sandoval, A, Bird, P, Rowland, R, Sheehy, S, Poulton, I, Hutchings, C, Todryk, S, Andrews, L, Folgori, A, Berrie, E, Moyle, S, Nicosia, A, Colloca, S, Cortese, R, Siani, L, Lawrie, A, Gilbert, S, Hill, A

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation by Ewer, K, O'Hara, G, Duncan, C, Collins, K, Sheehy, S, Reyes-Sandoval, A, Goodman, A, Edwards, N, Elias, S, Halstead, F, Longley, R, Rowland, R, Poulton, I, Draper, S, Blagborough, A, Berrie, E, Moyle, S, Williams, N, Siani, L, Folgori, A, Colloca, S, Sinden, R, Lawrie, A, Cortese, R, Gilbert, S, Nicosia, A, Hill, A

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. by Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Collins, K, Halstead, F, Elias, S, Lillie, P, Rausch, K, Aebig, J, Miura, K, Edwards, N, Poulton, I, Hunt-Cooke, A, Porter, D, Thompson, F, Rowland, R, Draper, S, Gilbert, S, Fay, M, Long, C, Zhu, D, Wu, Y, Martin, L, Anderson, C, Lawrie, A, Hill, A, Ellis, R

Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01 by Payne, R, Milne, K, Elias, S, Edwards, N, Douglas, A, Brown, R, Silk, S, Biswas, S, Miura, K, Roberts, R, Rampling, T, Venkatraman, N, Hodgson, S, Labbé, G, Halstead, F, Poulton, I, Nugent, F, de Graaf, H, Sukhtankar, P, Williams, N, Ockenhouse, C, Kathcart, A, Qabar, A, Waters, N, Soisson, L, Birkett, A, Cooke, G, Faust, S, Woods, C, Ivinson, K, McCarthy, J, Diggs, C, Vekemans, J, Long, C, Hill, A, Lawrie, A, Dutta, S, Draper, S